p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis

Shinichi Yachida, Michiie Sakamoto, Katsumi Imaida, Masanao Yokohira, Kousuke Saoo, Keiichi Okano, Hisao Wakabayashi, Hajime Maeta, Yasuyuki Suzuki

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to more malignant forms. Despite the demonstrated importance of cell-cycle regulators in tumor biology, there have been few studies of their role in multistep hepatocarcinogenesis. Expression of p27Kip1 and a degradation pathway associated protein, S-phase kinase-interacting protein 2 (Skp2), was therefore evaluated in surgically resected specimens of eight adenomatous hyperplasias, 16 early HCC and 126 classical HCC. Immunohistochemistry revealed no p27Kip1 expression in the majority of hepatocytes from normal and cirrhotic liver, whereas positive staining for p27Kip1 protein was found in 75.0% and 93.8% of adenomatous hyperplasias and early HCC, respectively. The average p27Kip1 labeling indices (LI) for adenomatous hyperplasias, early HCC, well differentiated HCC, moderately differentiated HCC and poorly differentiated HCC were 36.99, 43.59, 47.73, 49.24, and 30.21, respectively. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analyses confirmed the increases. Skp2 LI were also significantly elevated in accordance with stepwise progression of hepatocarcinogenesis. Increased expression of Skp2 mRNA was observed most frequently in less differentiated tumors and Kaplan-Meier survival analysis showed a significantly association with a poor prognosis (P = 0.0496). In conclusion, a high level of p27Kip1 expression is evident from early stages of hepatocarcinogenesis, indicating that this parameter could be a useful diagnostic marker for precancerous lesions and early HCC. In addition, Skp2 expression correlates with tumor dedifferentiation and may contribute to biological aggression in HCC.

Original languageEnglish
Pages (from-to)2152-2159
Number of pages8
JournalCancer Science
Volume99
Issue number11
DOIs
Publication statusPublished - 2008

Fingerprint

Hepatocellular Carcinoma
S Phase
Protein Kinases
Hyperplasia
S-Phase Kinase-Associated Proteins
Cyclin-Dependent Kinase Inhibitor p27
Neoplasms
Kaplan-Meier Estimate
Survival Analysis
Aggression
Reverse Transcription
Liver Diseases
Hepatocytes
Cell Cycle
Chronic Disease
Immunohistochemistry
Staining and Labeling
Polymerase Chain Reaction
Messenger RNA
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yachida, S., Sakamoto, M., Imaida, K., Yokohira, M., Saoo, K., Okano, K., ... Suzuki, Y. (2008). p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis. Cancer Science, 99(11), 2152-2159. https://doi.org/10.1111/j.1349-7006.2008.00923.x

p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis. / Yachida, Shinichi; Sakamoto, Michiie; Imaida, Katsumi; Yokohira, Masanao; Saoo, Kousuke; Okano, Keiichi; Wakabayashi, Hisao; Maeta, Hajime; Suzuki, Yasuyuki.

In: Cancer Science, Vol. 99, No. 11, 2008, p. 2152-2159.

Research output: Contribution to journalArticle

Yachida, S, Sakamoto, M, Imaida, K, Yokohira, M, Saoo, K, Okano, K, Wakabayashi, H, Maeta, H & Suzuki, Y 2008, 'p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis', Cancer Science, vol. 99, no. 11, pp. 2152-2159. https://doi.org/10.1111/j.1349-7006.2008.00923.x
Yachida, Shinichi ; Sakamoto, Michiie ; Imaida, Katsumi ; Yokohira, Masanao ; Saoo, Kousuke ; Okano, Keiichi ; Wakabayashi, Hisao ; Maeta, Hajime ; Suzuki, Yasuyuki. / p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis. In: Cancer Science. 2008 ; Vol. 99, No. 11. pp. 2152-2159.
@article{ec0994f806ab4f5b88f6f2f506e0bc13,
title = "p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis",
abstract = "Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to more malignant forms. Despite the demonstrated importance of cell-cycle regulators in tumor biology, there have been few studies of their role in multistep hepatocarcinogenesis. Expression of p27Kip1 and a degradation pathway associated protein, S-phase kinase-interacting protein 2 (Skp2), was therefore evaluated in surgically resected specimens of eight adenomatous hyperplasias, 16 early HCC and 126 classical HCC. Immunohistochemistry revealed no p27Kip1 expression in the majority of hepatocytes from normal and cirrhotic liver, whereas positive staining for p27Kip1 protein was found in 75.0{\%} and 93.8{\%} of adenomatous hyperplasias and early HCC, respectively. The average p27Kip1 labeling indices (LI) for adenomatous hyperplasias, early HCC, well differentiated HCC, moderately differentiated HCC and poorly differentiated HCC were 36.99, 43.59, 47.73, 49.24, and 30.21, respectively. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analyses confirmed the increases. Skp2 LI were also significantly elevated in accordance with stepwise progression of hepatocarcinogenesis. Increased expression of Skp2 mRNA was observed most frequently in less differentiated tumors and Kaplan-Meier survival analysis showed a significantly association with a poor prognosis (P = 0.0496). In conclusion, a high level of p27Kip1 expression is evident from early stages of hepatocarcinogenesis, indicating that this parameter could be a useful diagnostic marker for precancerous lesions and early HCC. In addition, Skp2 expression correlates with tumor dedifferentiation and may contribute to biological aggression in HCC.",
author = "Shinichi Yachida and Michiie Sakamoto and Katsumi Imaida and Masanao Yokohira and Kousuke Saoo and Keiichi Okano and Hisao Wakabayashi and Hajime Maeta and Yasuyuki Suzuki",
year = "2008",
doi = "10.1111/j.1349-7006.2008.00923.x",
language = "English",
volume = "99",
pages = "2152--2159",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - p27Kip1 is overexpressed in very early stages of hepatocarcinogenesis

AU - Yachida, Shinichi

AU - Sakamoto, Michiie

AU - Imaida, Katsumi

AU - Yokohira, Masanao

AU - Saoo, Kousuke

AU - Okano, Keiichi

AU - Wakabayashi, Hisao

AU - Maeta, Hajime

AU - Suzuki, Yasuyuki

PY - 2008

Y1 - 2008

N2 - Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to more malignant forms. Despite the demonstrated importance of cell-cycle regulators in tumor biology, there have been few studies of their role in multistep hepatocarcinogenesis. Expression of p27Kip1 and a degradation pathway associated protein, S-phase kinase-interacting protein 2 (Skp2), was therefore evaluated in surgically resected specimens of eight adenomatous hyperplasias, 16 early HCC and 126 classical HCC. Immunohistochemistry revealed no p27Kip1 expression in the majority of hepatocytes from normal and cirrhotic liver, whereas positive staining for p27Kip1 protein was found in 75.0% and 93.8% of adenomatous hyperplasias and early HCC, respectively. The average p27Kip1 labeling indices (LI) for adenomatous hyperplasias, early HCC, well differentiated HCC, moderately differentiated HCC and poorly differentiated HCC were 36.99, 43.59, 47.73, 49.24, and 30.21, respectively. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analyses confirmed the increases. Skp2 LI were also significantly elevated in accordance with stepwise progression of hepatocarcinogenesis. Increased expression of Skp2 mRNA was observed most frequently in less differentiated tumors and Kaplan-Meier survival analysis showed a significantly association with a poor prognosis (P = 0.0496). In conclusion, a high level of p27Kip1 expression is evident from early stages of hepatocarcinogenesis, indicating that this parameter could be a useful diagnostic marker for precancerous lesions and early HCC. In addition, Skp2 expression correlates with tumor dedifferentiation and may contribute to biological aggression in HCC.

AB - Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to more malignant forms. Despite the demonstrated importance of cell-cycle regulators in tumor biology, there have been few studies of their role in multistep hepatocarcinogenesis. Expression of p27Kip1 and a degradation pathway associated protein, S-phase kinase-interacting protein 2 (Skp2), was therefore evaluated in surgically resected specimens of eight adenomatous hyperplasias, 16 early HCC and 126 classical HCC. Immunohistochemistry revealed no p27Kip1 expression in the majority of hepatocytes from normal and cirrhotic liver, whereas positive staining for p27Kip1 protein was found in 75.0% and 93.8% of adenomatous hyperplasias and early HCC, respectively. The average p27Kip1 labeling indices (LI) for adenomatous hyperplasias, early HCC, well differentiated HCC, moderately differentiated HCC and poorly differentiated HCC were 36.99, 43.59, 47.73, 49.24, and 30.21, respectively. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analyses confirmed the increases. Skp2 LI were also significantly elevated in accordance with stepwise progression of hepatocarcinogenesis. Increased expression of Skp2 mRNA was observed most frequently in less differentiated tumors and Kaplan-Meier survival analysis showed a significantly association with a poor prognosis (P = 0.0496). In conclusion, a high level of p27Kip1 expression is evident from early stages of hepatocarcinogenesis, indicating that this parameter could be a useful diagnostic marker for precancerous lesions and early HCC. In addition, Skp2 expression correlates with tumor dedifferentiation and may contribute to biological aggression in HCC.

UR - http://www.scopus.com/inward/record.url?scp=55449109546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55449109546&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2008.00923.x

DO - 10.1111/j.1349-7006.2008.00923.x

M3 - Article

C2 - 18808421

AN - SCOPUS:55449109546

VL - 99

SP - 2152

EP - 2159

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 11

ER -